Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1039 of 1,261

  1. EP 2035418

    NEUE HETEROARYLSUBSTITUIERTE BENZOXAZOLE

    ASTRAZENECA AB [SE] · Granted Mar 18, 2009 · Expires Mar 13, 2029

    granted

  2. US 7504109

    Influenza hemagglutinin and neuraminidase variants

    The United States of America as Represented by The Department of Health Services, National Institute of Health · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  3. US 7504233

    Methods for determining the metabolism of sugars and fats in an individual

    The Regents of the University of California · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  4. US 7504398

    Substituted-4-(pyrrolo pyrimidin-6-yl)benzenesulphonamide derivatives

    Laboratories Almirall, S.A. · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  5. US 7504504

    Methods of preparing aripiprazole crystalline forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  6. US 7504101

    Methods for enhancing antigen-specific immune response using antibodies that bind OX-40

    Sisters of Providence in Oregon · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  7. US 7504515

    Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4- (oxazol-5-yl)phenyl) ureido)phenyl) ethylcarbamate

    Vertex Pharmaceuticals Incorporated · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  8. US 7504231

    Method of alleviating chronic pain via peripheral inhibition of neurotransmitter synthesis

    The Board of Regents of the University of Oklahoma · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  9. US 7504430

    Maleiimide anti-tumor phosphatase inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  10. US 7504096

    Methods for in vitro fertilization

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  11. US 7504435

    Method for stimulating weight loss and/or for lowering triglycerides in patients

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  12. US 7504246

    Hyaluronan synthase gene and uses thereof

    The Board of Regents of the University of Oklahoma · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  13. US 7504243

    Methods for the production of biliverdin

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  14. US 7501450

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  15. US 7501442

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  16. US 7501415

    Selective inhibitors of ERK protein kinase and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  17. US 7501448

    Process for preparing telmisartan

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  18. US 7501403

    Bile acid or bile salt fatty acid conjugates

    Galmed International Limited · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  19. US 7501132

    Multiple antigenic peptides immunogenic against Streptococcus pneumonia

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  20. US 7501494

    Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection

    United Biomedical, Inc. · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  21. US 7501260

    Methods for determining efficacy of chemotherapeutic agents for a patient prior to treatment

    Precision Therapeutics, Inc. · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  22. US 7501501

    MHC-Class II restricted melanoma antigens and their use in therapeutic methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  23. US 2009062719

    Enhanced PhotoDynamic Therapy with Immune System Assist

    NEUBERGER WOLFGANG [MY] · Granted Mar 5, 2009 · Expires Feb 28, 2029

    granted

  24. WO 2009026621

    COMPOSÉ ET COMPOSITION PHARMACEUTIQUES

    ALPHAPHARM PTY LTD [AU] · Granted Mar 5, 2009 · Expires Feb 28, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.